ES488796A0 - A MONACOLINE K PREPARATION PROCEDURE. - Google Patents

A MONACOLINE K PREPARATION PROCEDURE.

Info

Publication number
ES488796A0
ES488796A0 ES488796A ES488796A ES488796A0 ES 488796 A0 ES488796 A0 ES 488796A0 ES 488796 A ES488796 A ES 488796A ES 488796 A ES488796 A ES 488796A ES 488796 A0 ES488796 A0 ES 488796A0
Authority
ES
Spain
Prior art keywords
monacoline
preparation procedure
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES488796A
Other languages
Spanish (es)
Other versions
ES8103171A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES488796A0 publication Critical patent/ES488796A0/en
Publication of ES8103171A1 publication Critical patent/ES8103171A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
ES488796A 1979-02-20 1980-02-20 Antihypercholesteraemic Agent, Monacolin K, and Its Preparation Expired ES8103171A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (en) 1979-02-20 1979-02-20 New physiologically active substance monacolin K and its production method

Publications (2)

Publication Number Publication Date
ES488796A0 true ES488796A0 (en) 1981-02-16
ES8103171A1 ES8103171A1 (en) 1981-02-16

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488796A Expired ES8103171A1 (en) 1979-02-20 1980-02-20 Antihypercholesteraemic Agent, Monacolin K, and Its Preparation

Country Status (27)

Country Link
JP (1) JPS5925599B2 (en)
KR (1) KR830002801B1 (en)
AT (1) AT373915B (en)
AU (1) AU532626B2 (en)
BE (1) BE881825A (en)
CA (1) CA1129794A (en)
CH (1) CH645890A5 (en)
DD (1) DD154494A5 (en)
DE (2) DE3051175C2 (en)
DK (2) DK149095C (en)
ES (1) ES8103171A1 (en)
FI (1) FI66427C (en)
FR (1) FR2449685B1 (en)
GB (1) GB2046737B (en)
HU (1) HU182069B (en)
IE (1) IE49743B1 (en)
IT (1) IT1175260B (en)
MX (1) MX6314E (en)
NL (1) NL191540C (en)
NO (1) NO153974C (en)
NZ (1) NZ192919A (en)
PH (1) PH15145A (en)
PL (1) PL124304B1 (en)
SE (1) SE453301B (en)
SG (1) SG6784G (en)
SU (2) SU1158048A3 (en)
ZA (1) ZA80962B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (en) * 1980-03-31 1994-11-16 三共株式会社 MB-530A derivative
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (en) * 1980-06-06 1986-07-28 Sankyo Co METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES
JPS5835144A (en) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb-530b derivative and its preparation
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) * 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
JPH07504568A (en) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 Tetralin derivatives as HMG-CoA reductase inhibitors
ZA933359B (en) 1992-05-15 1993-12-08 Sankyo Co Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
AU753564B2 (en) 1998-03-20 2002-10-24 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
RU2265665C2 (en) 2000-02-24 2005-12-10 Тева Джиоджисзерджиар Ресзвенитаршашаг Method for purifying fermentation broth
JP2003525935A (en) 2000-03-03 2003-09-02 ビオガル ジョジセルジャール アール テー． Method for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
KR20010095780A (en) * 2000-04-12 2001-11-07 나가오카 마사시 Embryo monascus
IN192861B (en) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
DE60218822T2 (en) 2001-02-09 2007-07-12 Unilever N.V. FOODS CONTAINING SOY PROTEIN AND STATIN
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (en) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 Preventive and Dietary Supplement for adult chronic disease
KR100710500B1 (en) 2005-05-18 2007-04-24 고려대학교 산학협력단 Method for producing Monacolin K using Monascus sp
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
SI2373609T1 (en) 2008-12-19 2013-12-31 Krka, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (en) 2012-10-12 2013-09-30 Ion Gigel Fulga Composition for the treatment or prevention of dyslipidemias
CN110331151A (en) * 2019-04-11 2019-10-15 北京工商大学 The construction method of purple Monascus mokH gene overexpression bacterial strain
CN111297938A (en) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 Method for detecting lovastatin in composition for assisting in reducing blood fat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (en) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
IL60219A (en) * 1979-06-15 1985-05-31 Merck & Co Inc Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK73080A (en) 1980-08-21
NL191540C (en) 1995-09-04
ZA80962B (en) 1981-03-25
DD154494A5 (en) 1982-03-24
KR830002030A (en) 1983-05-21
IT1175260B (en) 1987-07-01
AU532626B2 (en) 1983-10-06
BE881825A (en) 1980-08-20
NZ192919A (en) 1984-07-06
IE800321L (en) 1980-08-20
DE3006216A1 (en) 1980-09-04
NO153974B (en) 1986-03-17
AT373915B (en) 1984-03-12
JPS55111790A (en) 1980-08-28
NL8001041A (en) 1980-08-22
IT8067262A0 (en) 1980-02-20
AU5567380A (en) 1980-08-28
MX6314E (en) 1985-04-01
ES8103171A1 (en) 1981-02-16
KR830002801B1 (en) 1983-12-16
PH15145A (en) 1982-08-24
SU969702A1 (en) 1982-10-30
NO800451L (en) 1980-08-21
DK21889A (en) 1989-01-18
DE3051175C2 (en) 1989-12-21
DK149095C (en) 1986-06-16
FR2449685B1 (en) 1985-06-28
FI800506A (en) 1980-08-21
DK149095B (en) 1986-01-20
FI66427C (en) 1984-10-10
FR2449685A1 (en) 1980-09-19
GB2046737B (en) 1983-01-12
NO153974C (en) 1986-06-25
PL124304B1 (en) 1983-01-31
HU182069B (en) 1983-12-28
NL191540B (en) 1995-05-01
CH645890A5 (en) 1984-10-31
JPS5925599B2 (en) 1984-06-19
GB2046737A (en) 1980-11-19
SG6784G (en) 1985-02-08
DE3006216C2 (en) 1985-10-31
IE49743B1 (en) 1985-12-11
FI66427B (en) 1984-06-29
SE453301B (en) 1988-01-25
DK21889D0 (en) 1989-01-18
SE8001339L (en) 1980-08-21
CA1129794A (en) 1982-08-17
PL222120A1 (en) 1980-10-20
SU1158048A3 (en) 1985-05-23
ATA92980A (en) 1983-07-15

Similar Documents

Publication Publication Date Title
ES488796A0 (en) A MONACOLINE K PREPARATION PROCEDURE.
NL180632C (en) ANTI-TRANSPIRATION PREPARATION.
FI850198A0 (en) EXPRESSIONSPLASMID.
ES497862A0 (en) A PREPARATION PROCEDURE OF 4.1 ', 6'-TRICLORO-4,1', 6 'TRIDESOXIGALACTOSACAROSA
ES495135A0 (en) A PROCEDURE FOR THE PREPARATION OF FIBER FORMING COPOLIESTERS.
ES491574A0 (en) PROCEDURE FOR PREPARING HERBICIDALLY ACTI-VOS DIFFENILETERS.
ES494131A0 (en) A PROCEDURE FOR THE PREPARATION OF DIARYLTHIOPHENES.
ES256673Y (en) GUARDAVISTAS.
NO802770L (en) PAPIRBELEGNINGSPIGMENTER.
ES491944A0 (en) A PROCEDURE FOR THE PREPARATION OF TIENAMICINES.
ES262173Y (en) A COUPLING SET.
ES491835A0 (en) A PROCEDURE FOR THE PREPARATION OF MONO-Y-DI-ESTERES DESACAROSA.
NO782832L (en) ANTITRANSPIRATION PREPARATION.
ES254327Y (en) PORTILLON.
NL175881C (en) VAGRAMINATING PREPARATION.
FI73548B (en) OEVERSTROEMSKYDDSKRETS FOER EFFEKTTRANSISTOR.
NO780932L (en) ANTI-GROINSG PREPARATION.
ES490277A0 (en) A PROCEDURE FOR THE PREPARATION OF AMINOETERES.
RO77532A (en) VINDEZINE PREPARATION PROCEDURE
ES488580A0 (en) A PERFECT LOCKING DEVICE.
IT8023753A0 (en) CHOLECALCIFEROL-DERIVATIVES.
NL7803291A (en) ANTI-MICROBEN PREPARATION.
FI73539B (en) MULTIPLEXANSLUTNINGSENHET FOER EN DIGITALSTATION.
ES491136A0 (en) A PROCEDURE FOR THE PREPARATION OF IMIDAZO-PIRIDINAS.
ES492747A0 (en) 2-ISOPROPYLAMINE-PIRIMIDINE PREPARATION PROCEDURE.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010217